Advice
Pegylated interferon alfa-2b is an appropriate treatment for the management of adult patients with chronic hepatitis C under the overall supervision of specialists experienced in the management of this disorder.
REASONS FOR ADVICE.
This treatment involves a once weekly injection that reduces inconvenience to patients whilst increasing the response rate to both Pegylated interferon alfa-2b alone or in combination with Ribavirin.
Download detailed advice17KB (PDF)
Medicine details
- Medicine name:
- pegylated interferon alfa-2b (ViraferonPeg)
- SMC ID:
- 02/02
- Indication:
- Chronic hepatitis C
- Pharmaceutical company
- Schering-Plough Ltd
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 10 May 2002